| 1 |
Biomarkers in the setting of benign prostatic hyperplasia-induced lower urinary tract symptoms: what an interventional radiologist needs to know |
|
|
| Shamar Young,Alessandro Gasparetto,Hamed Jalaeian,Jafar Golzarian |
|
| The British Journal of Radiology. 2020; : 20200484 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
How should radiologists incorporate non-imaging prostate cancer biomarkers into daily practice? |
|
|
| Pawel Rajwa,Jamil Syed,Michael S. Leapman |
|
| Abdominal Radiology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis |
|
|
| Wieke C. H. Visser,Hans de Jong,Willem J. G. Melchers,Peter F. A. Mulders,Jack A. Schalken |
|
| Cancers. 2020; 12(12): 3790 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Non-invasive prostate cancer screening using chemometric processing of macro and trace element concentration profiles in urine |
|
|
| Ekaterina Martynko,Ekaterina Oleneva,Evgeny Andreev,Sergey Savinov,Svetlana Solovieva,Vladimir Protoshchak,Evgenii Karpushchenko,Aleksandr Sleptsov,Vitaly Panchuk,Andrey Legin,Dmitry Kirsanov |
|
| Microchemical Journal. 2020; : 105464 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Diagnostic performance of the prostate cancer antigen 3 test in Prostate Cancer: A systematic review and meta-analysis |
|
|
| Donghyun Lee,Sung Ryul Shim,Sun Tae Ahn,Mi Mi Oh,Du Geon Moon,Hong Seok Park,Jun Cheon,Jong Wook Kim |
|
| Clinical Genitourinary Cancer. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Biomarkers for detecting prostate cancer |
|
|
| Junhai Jia,Yue Sun,Jingjie Ren,Muyang Li,Jiancheng Wang,Haiyang Li |
|
| Medicine. 2019; 98(30): e16517 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
New biomarkers for diagnosis and prognosis of localized prostate cancer |
|
|
| Dimitry A. Chistiakov,Veronika A. Myasoedova,Andrey V. Grechko,Alexandra A. Melnichenko,Alexander N. Orekhov |
|
| Seminars in Cancer Biology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Urinary extracellular vesicle biomarkers in urological cancers: From discovery towards clinical implementation |
|
|
| Bert Dhondt,Jan Van Deun,Silke Vermaerke,Ario de Marco,Nicolaas Lumen,Olivier De Wever,An Hendrix |
|
| The International Journal of Biochemistry & Cell Biology. 2018; 99: 236 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Long non-coding RNAs in prostate cancer: Biological and clinical implications |
|
|
| Rajdeep Das,Felix Y. Feng,Luke A. Selth |
|
| Molecular and Cellular Endocrinology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Forecasting, uncertainty and risk; perspectives on clinical decision-making in preventive and curative medicine |
|
|
| Spyros Makridakis,Richard Kirkham,Ann Wakefield,Maria Papadaki,Joanne Kirkham,Lisa Long |
|
| International Journal of Forecasting. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5a-reductase inhibitors |
|
|
| Vincent Fradet,Paul Toren,Molière Nguile-Makao,Michele Lodde,Jérome Lévesque,Caroline Léger,André Caron,Alain Bergeron,Tal Ben-Zvi,Louis Lacombe,Frédéric Pouliot,Rabi Tiguert,Thierry Dujardin,Yves Fradet |
|
| BJU International. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy |
|
|
| Vito Cucchiara,Joy Yang,Vincenzo Mirone,Allen Gao,Michael Rosenfeld,Christopher Evans |
|
| Cancers. 2017; 9(1): 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Urinary biomarkers in prostate cancer detection and monitoring progression |
|
|
| Duojia Wu,Jie Ni,Julia Beretov,Paul Cozzi,Mark Willcox,Valerie Wasinger,Bradley Walsh,Peter Graham,Yong Li |
|
| Critical Reviews in Oncology/Hematology. 2017; 118: 15 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Low-risk Prostate Cancer: Identification, Management, and Outcomes |
|
|
| Marco Moschini,Peter R. Carroll,Scott E. Eggener,Jonathan I. Epstein,Markus Graefen,Rodolfo Montironi,Christopher Parker |
|
| European Urology. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance |
|
|
| J J Tosoian,H D Patel,M Mamawala,P Landis,S Wolf,D J Elliott,J I Epstein,H B Carter,A E Ross,L J Sokoll,C P Pavlovich |
|
| Prostate Cancer and Prostatic Diseases. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements |
|
|
| Pierre-Olivier Gaudreau,John Stagg,Denis Soulières,Fred Saad |
|
| Biomarkers in Cancer. 2016; 8s2: BIC.S31802 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Recent progress and perspectives on prostate cancer biomarkers |
|
|
| Shingo Hatakeyama,Tohru Yoneyama,Yuki Tobisawa,Chikara Ohyama |
|
| International Journal of Clinical Oncology. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Novel gene expression signature predictive of clinical recurrence after radical prostatectomy in early stage prostate cancer patients |
|
|
| Ahva Shahabi,Juan Pablo Lewinger,Jie Ren,Craig April,Andy E. Sherrod,Joseph G. Hacia,Siamak Daneshmand,Inderbir Gill,Jacek K. Pinski,Jian-Bing Fan,Mariana C. Stern |
|
| The Prostate. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Biomarkers in localized prostate cancer |
|
|
| Matteo Ferro,Carlo Buonerba,Daniela Terracciano,Giuseppe Lucarelli,Vincenzo Cosimato,Danilo Bottero,Victor M Deliu,Pasquale Ditonno,Sisto Perdonà,Riccardo Autorino,Ioman Coman,Sabino De Placido,Giuseppe Di Lorenzo,Ottavio De Cobelli |
|
| Future Oncology. 2016; 12(3): 399 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Urinary Biomarkers for Prostate Cancer |
|
|
| Jeffrey J. Tosoian,Ashley E. Ross,Lori J. Sokoll,Alan W. Partin,Christian P. Pavlovich |
|
| Urologic Clinics of North America. 2016; 43(1): 17 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Urinary biomarkers for prostate cancer |
|
|
| John T. Wei |
|
| Current Opinion in Urology. 2015; 25(1): 77 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience |
|
|
| Roberta Merola,Luigi Tomao,Anna Antenucci,Isabella Sperduti,Steno Sentinelli,Serena Masi,Chiara Mandoj,Giulia Orlandi,Rocco Papalia,Salvatore Guaglianone,Manuela Costantini,Giuseppe Cusumano,Giovanni Cigliana,Paolo Ascenzi,Michele Gallucci,Laura Conti |
|
| Journal of Experimental & Clinical Cancer Research. 2015; 34(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Screening for Prostate Cancer—Beyond Total PSA, Utilization of Novel Biomarkers |
|
|
| Todd Morgan,Ganesh Palapattu,John Wei |
|
| Current Urology Reports. 2015; 16(9) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Emerging biomarkers in the detection and prognosis of prostate cancer |
|
|
| Xavier Filella,Laura Foj |
|
| Clinical Chemistry and Laboratory Medicine (CCLM). 2015; 53(7) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation |
|
|
| Amanda Nicholson,James Mahon,Angela Boland,Sophie Beale,Kerry Dwan,Nigel Fleeman,Juliet Hockenhull,Yenal Dundar |
|
| Health Technology Assessment. 2015; 19(87): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
